Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)Post-Market Clinical Investigation of NanoFUSE® Bioactive Matrix
Phase 4
- Conditions
- Bone; Degeneration
- First Posted Date
- 2018-12-04
- Last Posted Date
- 2018-12-04
- Lead Sponsor
- NanoFUSE Biologics, LLC
- Target Recruit Count
- 100
- Registration Number
- NCT03762811
NanoFUSE® PL Gutter PMCF
Phase 4
- Conditions
- Degenerative Disc Disease
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2018-11-23
- Lead Sponsor
- NanoFUSE Biologics, LLC
- Target Recruit Count
- 50
- Registration Number
- NCT03751943
News
No news found